Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “glp1 Agonist”

258 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 258 results

Not applicableNot Yet RecruitingNCT07567378
What this trial is testing

CARTIZ Registry: Cartilage, Arthropathy and Imaging Under Tirzepatide in Zone-stratified Cohorts - A Four-Institute Mexican Observational Registry

Who this might be right for
Psoriatic ArthritisOsteoarthitisKnee+12 more
JULIO GRANADOS MONTIEL 30
Not applicableUnknownNCT05268627
What this trial is testing

Endoscopic Ultrasound Guided Gastric Botulinum Toxin Injections Versus Glucagon Like Peptide 1 Receptor Agonist in Weight Loss

Who this might be right for
Obesity
Mansoura University 38
Not applicableLooking for participantsNCT07195994
What this trial is testing

A Clinical Trial to Examine the Efficacy and Safety of an Investigational Product With and Without Use of Semaglutide on Glycemic Response in Adults With Prediabetes or Type 2 Diabetes

Who this might be right for
Prediabetes / Type 2 Diabetes
QuickSilver Scientific 90
Post-approval studies (Phase 4)Looking for participantsNCT06901245
What this trial is testing

Tirzepatide in PWS, HO and GNSO

Who this might be right for
Prader-Willi SyndromeHypothalamic ObesityObesity/Therapy
Grace Kim 36
Large-scale testing (Phase 3)Study completedNCT00707031
What this trial is testing

GLP-1 Receptor Agonist Lixisenatide Versus Exenatide in Patients With Type 2 Diabetes for Glycemic Control and Safety Evaluation, on Top of Metformin

Who this might be right for
Diabetes Mellitus, Type 2
Sanofi 639
Post-approval studies (Phase 4)Study completedNCT01899430
What this trial is testing

Polycystic Ovary Syndrome and Liraglutide

Who this might be right for
PCOSObesity
University Medical Centre Ljubljana 32
Post-approval studies (Phase 4)Looking for participantsNCT06774079
What this trial is testing

Glucagon-like Peptide-1 Receptor Agonist (GLP-1 RA) and Diet in Inflammatory Bowel Disease (IBD) Patients

Who this might be right for
Crohn Disease
University of Miami 24
Large-scale testing (Phase 3)Study completedNCT00688701
What this trial is testing

GLP-1 Receptor Agonist Lixisenatide in Patients With Type 2 Diabetes for Glycemic Control and Safety Evaluation in Monotherapy

Who this might be right for
Diabetes Mellitus, Type 2
Sanofi 361
Not applicableStudy completedNCT06500130
What this trial is testing

Effects of Liraglutide on Body Surface Gastric Mapping

Who this might be right for
GastroparesisFunctional DyspepsiaChronic Nausea and Vomiting Syndrome+1 more
Alimetry 22
Large-scale testing (Phase 3)Looking for participantsNCT05569772
What this trial is testing

Semaglutide for the Treatment of Glucose Intolerance in Women With Prior Gestational Diabetes

Who this might be right for
Glucose Intolerance After a Recent History of Gestational Diabetes
Universitaire Ziekenhuizen KU Leuven 252
Testing effectiveness (Phase 2)Looking for participantsNCT07220473
What this trial is testing

Tirzepatide to Slow Biological Aging

Who this might be right for
AgingLONGEVITY 1
The University of Texas Medical Branch, Galveston 90
Not applicableNot Yet RecruitingNCT07558603
What this trial is testing

Evaluate the Safety and Efficacy of AGE Serum in Post-menopausal Patients on Hormone Replacement Therapy Taking Glucagon-like Peptide-1 Agonist

Who this might be right for
Laxity; Skin
Goldman, Butterwick, Fitzpatrick and Groff 50
Early research (Phase 1)Ended earlyNCT03645408
What this trial is testing

The Effects of Exenatide, a GLP-1 Agonist, on Alcohol Self-Administration in Heavy Drinkers

Who this might be right for
Alcohol Use Disorder
Boston Medical Center 8
Post-approval studies (Phase 4)Enrolling By InvitationNCT07117240
What this trial is testing

Evaluation of the Efficacy and Safety of GLP-1 Receptor Agonist Therapy In Steroid-Induced Diabetes

Who this might be right for
Steroid-Induced DiabetesSteroid-Induced HyperglycemiaDiabetes
Medical University of Warsaw 100
Large-scale testing (Phase 3)Not Yet RecruitingNCT07218354
What this trial is testing

Cessation or Reduction of Alcohol Consumption in Veterans: A Randomized, Double-Blind, Placebo-Controlled Phase 3 Trial to Evaluate the Efficacy and Safety of a GLP-1 Receptor Agonist Semaglutide in U.S. Veterans With Alcohol Use Disorder

Who this might be right for
Alcohol Use Disorder
VA Office of Research and Development 622
Testing effectiveness (Phase 2)Looking for participantsNCT07446998
What this trial is testing

Proof-of-Concept Study Evaluating Total Body Weight, Physical Function & Safety of Enobosarm in Patients Treated With GLP-1 Receptor Agonist, for Weight Loss

Who this might be right for
Obesity & OverweightMobility DisabilityHOMA-IR
Veru Inc. 200
Not applicableStudy completedNCT01281228
What this trial is testing

The Effect of GLP-1 Receptor Activation on Central Reward and Satiety in Obesity and Diabetes

Who this might be right for
Diabetes MellitusDiabetes Mellitus, Type 2Obesity
Amsterdam UMC, location VUmc 48
Large-scale testing (Phase 3)Looking for participantsNCT07284511
What this trial is testing

A Clinical Trial Using Tirzepatide to Help Adults With Type 1 Diabetes Automatically Control Their Blood Sugar

Who this might be right for
Type 1 DiabetesType 1 Diabetes MellitusT1D+2 more
McGill University Health Centre/Research Institute of the McGill University Health Centre 105
Post-approval studies (Phase 4)Study completedNCT02465515
What this trial is testing

Effect of Albiglutide, When Added to Standard Blood Glucose Lowering Therapies, on Major Cardiovascular Events in Subjects With Type 2 Diabetes Mellitus

Who this might be right for
Diabetes Mellitus
GlaxoSmithKline 9,463
Large-scale testing (Phase 3)Study completedNCT00712673
What this trial is testing

GLP-1 Receptor Agonist Lixisenatide (Morning or Evening) in Patients With Type 2 Diabetes for Glycemic Control and Safety Evaluation, on Top of Metformin

Who this might be right for
Diabetes Mellitus, Type 2
Sanofi 680
Load More Results